Sökning: onr:"swepub:oai:DiVA.org:uu-531098" >
Impact of the COVID...
Impact of the COVID-19 pandemic on lymphoma incidence and short-term survival - a Swedish Lymphoma Register Study
-
- Ekberg, Sara (författare)
- Karolinska Inst, Dept Med Solna, Clin Epidemiol Div, SE-17176 Stockholm, Sweden.
-
- Molin, Daniel, 1969- (författare)
- Uppsala universitet,Cancerimmunterapi
-
- Pahnke, Simon (författare)
- Uppsala universitet,Cancerprecisionsmedicin
-
visa fler...
-
- Bergstroem, Fanny (författare)
- Karolinska Inst, Dept Med Solna, Clin Epidemiol Div, SE-17176 Stockholm, Sweden.
-
- Branvall, Elsa (författare)
- Karolinska Institutet
-
- Smedby, Karin E. (författare)
- Karolinska Institutet,Karolinska Inst, Dept Med Solna, Clin Epidemiol Div, SE-17176 Stockholm, Sweden.;Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden.
-
- Waesterlid, Tove (författare)
- Karolinska Institutet,Karolinska Inst, Dept Med Solna, Clin Epidemiol Div, SE-17176 Stockholm, Sweden.;Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden.;Karolinska Inst, Dept Med Solna, SE-17176 Stockholm, Sweden.
-
visa färre...
-
Karolinska Inst, Dept Med Solna, Clin Epidemiol Div, SE-17176 Stockholm, Sweden Cancerimmunterapi (creator_code:org_t)
- Medical Journals Sweden, 2024
- 2024
- Engelska.
-
Ingår i: Acta Oncologica. - : Medical Journals Sweden. - 0284-186X .- 1651-226X. ; 63, s. 164-168
- Relaterad länk:
-
https://doi.org/10.2...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://urn.kb.se/re...
-
https://doi.org/10.2...
-
http://kipublication...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background & purpose: The COVID-19 pandemic posed a large challenge for healthcare systems across the world. Comprehensive data on the impact of the COVID-19 pandemic on incidence and mortality in lymphoma are lacking.Patients/methods: Using data from the Swedish lymphoma register, we compare incidence and 1-year survival of lymphoma patients in Sweden before (2017-2019) and during the pandemic (2020 and 2021).Results: Fewer patients were diagnosed with lymphomas during March-June 2020, but the annual incidence rates for 2020 and 2021 were similar to those of 2017-2019. A larger proportion of patients presented with stage IV disease during 2021. There were no differences in other base-line characteristics nor application of active treatment in pre-pandemic and pandemic years. One-year overall survival was not inferior among lymphoma patients during the pandemic years compared to pre-pandemic years i.e., 2017-2019.Interpretation: The COVID-19 pandemic had limited impact on the incidence and mortality of lymphoma in Sweden.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap -- Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences -- Public Health, Global Health, Social Medicine and Epidemiology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Hematologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Hematology (hsv//eng)
Nyckelord
- COVID-19
- pandemic
- lymphoma
- incidence
- mortality
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas